During the past decade, Washington Hospital Center-MedStar Research Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington Hospital Center-MedStar Research Institute" #1 sponsor was "Halozyme Therapeutics" with 2 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "Chiesi USA, Inc." with 1 trials sponsored, "Joslin Diabetes Center" with 1 trials sponsored and "Momenta Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington Hospital Center-MedStar Research Institute" #1 collaborator was "Duke University" with 1 trials as a collaborator, "EKOS Corporation" with 1 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Washington Hospital Center-MedStar Research Institute" are "Atherosclerosis" (1 trials), "Chronic Hepatitis C" (1 trials), "Chronic Total Occlusion" (1 trials), "Coronary Artery Disease" (1 trials) and "Coronary Artery Disease (CAD)" (1 trials). Many other conditions were trialed in "Washington Hospital Center-MedStar Research Institute" in a lesser frequency.

Most popular intervention types in "Washington Hospital Center-MedStar Research Institute" are "Drug" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Insulin aspart" (2 trials), "Insulin glargine" (2 trials), "Insulin glulisine" (2 trials), "Insulin lispro" (2 trials) and "AST-120" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington Hospital Center-MedStar Research Institute" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Washington Hospital Center-MedStar Research Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Washington Hospital Center-MedStar Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Washington Hospital Center-MedStar Research Institute, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".